Cytodyn Inc (CYDY)

Currency in USD
0.2575
-0.0045(-1.72%)
Closed·
CYDY Scorecard
Full Analysis
Stock has taken a big hit over the last week
CYDY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.25250.2650
52 wk Range
0.10310.4945
Key Statistics
Prev. Close
0.262
Open
0.2602
Day's Range
0.2525-0.265
52 wk Range
0.1031-0.4945
Volume
1.32M
Average Volume (3m)
1.91M
1-Year Change
101.49%
Book Value / Share
-0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYDY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Cytodyn Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Cytodyn Inc Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company’s leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Compare CYDY to Peers and Sector

Metrics to compare
CYDY
Peers
Sector
Relationship
P/E Ratio
142.7x−4.5x−0.5x
PEG Ratio
1.400.020.00
Price/Book
−3.4x2.7x2.6x
Price / LTM Sales
-150.6x3.3x
Upside (Analyst Target)
-187.1%43.5%
Fair Value Upside
Unlock3.5%6.8%Unlock

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CYDY Income Statement

People Also Watch

119.41
GILD
+8.28%
1.4100
INO
-2.08%
250.89
UNH
+2.54%
563.00
REGN
+0.57%
147.56
QCOM
+1.14%

FAQ

What Stock Exchange Does Cytodyn Inc Trade On?

Cytodyn Inc is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Cytodyn Inc?

The stock symbol for Cytodyn Inc is "CYDY."

What Is the Cytodyn Inc Market Cap?

As of today, Cytodyn Inc market cap is 322.85M.

What Is Cytodyn Inc's Earnings Per Share (TTM)?

The Cytodyn Inc EPS (TTM) is 0.00.

When Is the Next Cytodyn Inc Earnings Date?

Cytodyn Inc will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is CYDY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cytodyn Inc Stock Split?

Cytodyn Inc has split 0 times.

How Many Employees Does Cytodyn Inc Have?

Cytodyn Inc has 13 employees.

What is the current trading status of Cytodyn Inc (CYDY)?

As of 09 Aug 2025, Cytodyn Inc (CYDY) is trading at a price of 0.26, with a previous close of 0.26. The stock has fluctuated within a day range of 0.25 to 0.27, while its 52-week range spans from 0.10 to 0.49.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.